BioCurex, Inc.(fka BOCX)

[GPKOCHMAN]

The internal auditors said nothing about the SEC filings or their accuracy except that there is the possibility of financial restatement(s) if BOCX identifies errors in securities transactions. They referred to a material weakness in the accounting controls within Biocurex that had to be referenced in filings to comply with Sarbanes-Oxley